RVPH · Reviva Pharmaceuticals Holdings, Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt regarding the Company's ability to continue as a going concern for a period of one year after the date the consolidated financial statements are issued. ... These circumstances raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.”View the 10-Q filed Aug 12, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Every disclosed holder of RVPH in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns RVPH
13F quarter Sep 30, 2026, combined view: filers that have not filed yet carry their Jun 30, 2026 positions| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 7,102 | 0.05% |
| Insiders (Forms 3, 4, 5) | 0 | 0.00% |
| 13D/G-only blocks | 3,738,624 | 28.52% |
| Remaining | 9,364,651 | 71.43% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 13,110,377, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of RVPH
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
|
1,072,690 | ||
| 2 |
|
672,811 | ||
| 3 |
HIGHBRIDGE CAPITAL MANAGEMENT LLC
13G
CIK 919185 · Registered investment adviser · Jun 30, 2025
Rule 13d-1(b), qualified institution
|
400,000 | ||
| 4 |
Parag Saxena
13D
CIK 1015823 · Unknown · Mar 20, 2026
Item 4 purpose: not restated by this amendment, the earlier 13D's purpose stands
|
363,280 | ||
| 5 |
|
312,580 | ||
| 6 |
Bhat Laxminarayan
13D
CIK 1818245 · Unknown · Sep 22, 2025
Item 4 purpose: not restated by this amendment, the earlier 13D's purpose stands
|
184,044 | ||
| 7 |
683 Capital Management, LLC
13G
CIK 1404574 · Registered investment adviser · Dec 31, 2025
Rule 13d-1(c), passive investor
|
174,625 | ||
| 8 |
TANG CAPITAL MANAGEMENT LLC
13G
CIK 1232621 · Unknown · Jun 30, 2025
Rule 13d-1(c), passive investor
|
169,999 | ||
| 9 |
ARMISTICE CAPITAL, LLC
13G
CIK 1601086 · Registered investment adviser · Sep 30, 2024
Rule 13d-1(b), qualified institution, unconfirmed, last confirmed Sep 30, 2024
|
167,898 | ||
| 10 |
TANG CAPITAL MANAGEMENT, LLC
13G
CIK 1191935 · Unknown · Dec 31, 2023
Rule 13d-1(c), passive investor, unconfirmed, last confirmed Dec 31, 2023
|
154,931 | ||
| 11 |
Schonfeld Strategic Advisors LLC
13G
CIK 1665241 · Registered investment adviser · Dec 31, 2024
Rule 13d-1(b), qualified institution
|
65,746 | ||
| 12 |
EMC Capital Management
13F
CIK 1847772 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
|
6,696 | ||
| 13 |
Purpose Unlimited Inc.
13F
CIK 2115120 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
|
405 | ||
| 14 |
|
20 | ||
| 15 |
Miller Global Investments, LLC
13F
CIK 2099097 · Registered investment adviser · Sep 30, 2026
|
1 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.